Melanoma Margins Trial: A Phase III, Multi-centre Randomised Controlled Trial


Lead Researcher: Professor Michael Henderson

Institution: University of Sydney (NSW)

Funding: $120,000

Funding Duration: 2014 - 2016

The Research

The results of the MelMarT study will provide the only available scientific evidence to support the appropriate and safe surgical  excision margin for primary melanoma and will establish recommended international treatment guidelines.


Similar research

No items found.